Monsanto rejects Bayer buyout, again
Tue., July 19, 2016
NEW YORK – Monsanto is rejecting the second takeover bid from Bayer.
The German drug and chemicals company last week boosted its offer from $62 billion, to about $65 billion, or $125 per share.
On Tuesday, Monsanto Co., a seed company, called revised offer inadequate, as it did the initial bid.
The St. Louis company said however that it remains open to talks with Bayer and others about a deal.
Local journalism is essential.
Give directly to The Spokesman-Review's Northwest Passages community forums series -- which helps to offset the costs of several reporter and editor positions at the newspaper -- by using the easy options below. Gifts processed in this system are not tax deductible, but are predominately used to help meet the local financial requirements needed to receive national matching-grant funds.
Subscribe now to get breaking news alerts in your email inbox
Get breaking news delivered to your inbox as it happens.